ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,107Medicare Part D Prescriptions Filled, Including Refills

Rank: 331 out of 4623

$691K Total Retail Price of All Prescriptions

Rank: 377 out of 4623

485 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,731 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 627 554 1 5
SIMVASTATIN 606 532 2 2
LEVOTHYROXINE SODIUM 605 535 3 1
LISINOPRIL 479 431 4 4
POTASSIUM CHLORIDE 374 363 5 14
OMEPRAZOLE 341 324 6 7
FUROSEMIDE 328 315 7 8
SERTRALINE HCL 258 236 8 26
METOPROLOL TARTRATE 241 223 9 9
METFORMIN HCL 231 194 10 6
CITALOPRAM HBR 227 202 11 23
HYDROCODONE-ACETAMINOPHEN 212 127 S3 12 3
METOPROLOL SUCCINATE 207 185 13 13
PRAVASTATIN SODIUM 201 170 14 11
FLUTICASONE PROPIONATE 175 130 15 32
DONEPEZIL HCL 170 170 16 30
WARFARIN SODIUM 164 162 17 24
ZOLPIDEM TARTRATE 153 99 18 18
GABAPENTIN 138 125 19 16
RAMIPRIL 122 122 20 76
MIRTAZAPINE 122 116 20 57
NEXIUM 119 97 22 17
ALENDRONATE SODIUM 116 116 23 22
CARVEDILOL 110 95 24 25
TRAMADOL HCL 109 100 25 15
NAMENDA 108 108 26 36
LOSARTAN POTASSIUM 106 93 27 21
QUETIAPINE FUMARATE 106 106 27 74
TAMSULOSIN HCL 106 103 27 29
POLYETHYLENE GLYCOL 3350 105 100 30 91
GLIMEPIRIDE 102 81 31 38
ALLOPURINOL 100 79 32 37
ATORVASTATIN CALCIUM 92 77 33 12
PANTOPRAZOLE SODIUM 92 72 33 35
LANTUS 87 80 35 44
DIOVAN 87 79 35 39
ATENOLOL 86 79 37 28
CRESTOR 77 64 38 20
DIGOXIN 73 72 39 58
TRAZODONE HCL 62 58 40 42
METFORMIN HCL ER 62 46 40 51
SPIRIVA 62 53 40 79
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 52 43 68
MELOXICAM 60 44 44 27
CYMBALTA 60 49 44 48
PLAVIX 59 57 46 45
NOVOLOG 59 59 46 123
DETROL LA 56 56 48 196
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 45 49 19
DILTIAZEM 24HR CD 52 52 50 156
CLONIDINE HCL 50 46 51 40
ISOSORBIDE MONONITRATE ER 50 50 51 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.